AMSTERDAM, November 3, 2011 /PRNewswire/ --
- App links SciVerse articles and abstracts to SciVal Funding, increasing discoverability of global funding opportunities
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the SciVal® Funding App for SciVerse®. The app links content from SciVerse ScienceDirect and SciVerse Scopus with SciVal Funding, Elsevier's online solution that provides targeted recommendations on grants, making it easier for researchers to discover funding opportunities related to their area of research.
The SciVal Funding App can be subscribed to or added for free in SciVerse Applications. It will retrieve up to five relevant funding opportunities to an abstract in SciVerse Scopus or SciVerse ScienceDirect. The app uses the Elsevier Fingerprint Engine[TM] to match active funding opportunities to the abstracts, delivering targeted funding recommendations directly into the researchers' workflow.
In addition to the launch of the app, SciVal Funding has expanded its geographic scope to Australia and Ireland. SciVal Funding now covers the United States, Canada, United Kingdom, European Union, Australia, and Ireland. This year more than 1,400 funding bodies have already been added to the initial 3,000 U.S.-based sources available on the platform. By the end of the year we aim to include funding bodies from Singapore, South Africa, and New Zealand.
"We continuously work on finding new ways to help researchers discover a maximum amount of international funding opportunities in the most practical way" said Niels Weertman, Vice President SciVal, Elsevier. "Through the SciVal Funding App more researchers will now be able to benefit from the virtues of SciVal Funding, while the continued global expansion of SciVal Funding ensures that researchers will be better equipped to identify the research funds available internationally."
About the Elsevier SciVal® Suite
Elsevier's SciVal suite of services supports academic and government leadership in evaluating, establishing and executing research strategies that optimize the performance of existing assets and maximize investments to enhance near and long-term productivity. SciVal tools leverage Scopus® data, Elsevier's trusted source of bibliometric data, to offer innovative yet authoritative solutions. Current suite offerings include: SciVal Spotlight™, a strategic tool that generates unique institutional and country maps of existing and emerging research strengths based on an interdisciplinary perspective of current performance; SciVal Funding™, an online solution that provides targeted recommendations on grants to pursue based on pre-populated research profiles and historical awards; SciVal Strata™, a web-based research performance tool that offers users the flexibility to construct relevant contextual data to evaluate research teams or individual researchers, using a range of indicators based on Scopus data; SciVal Experts, a semantic technology-based application that enables researchers to identify and locate sources of expertise at an individual or departmental level within and across institutions.
About the Elsevier SciVerse Suite
The SciVerse (http://www.sciverse.com) suite of search and discovery offerings provides the global research community access to a constantly expanding universe of content and solutions which can now be accessed in one platform. The suite currently includes SciVerse ScienceDirect (http://www.sciencedirect.com), the world's largest source of peer-reviewed content containing more than 10 million articles, and SciVerse Scopus (http://www.scopus.com), an abstract and citation database containing 41 million records, 70% with abstracts and nearly 18,000 titles from 5,000 publishers worldwide. The new platform also includes SciVerse Hub beta (http://www.hub.sciverse.com), which enables researchers to perform a single search across all of the SciVerse content as well as targeted web content with results ranked by relevancy and without duplication. SciVerse Applications beta (http://www.applications.sciverse.com), a new module within the suite, is a marketplace and developer network that allows the scientific community to build, find and use applications that enhance the SciVerse research experience.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).